Neha Desai
Diabetes mellitus is one of the significant public health challenges of
the 21st century, affecting millions worldwide. Traditional management
approaches often fall short of restoring normal glucose levels or
addressing underlying pathophysiological processes effectively. Stemcell
therapy has emerged as a promising avenue for diabetes treatment,
focusing on the regeneration of insulin-producing pancreatic β-cells and
the restoration of glucose homeostasis. This article reviews the current
state of stem-cell research in diabetes, discussing sources of stem cells,
mechanisms of action, clinical trials, and prospects for future therapies.
Despite the challenges, the potential of stem-cell therapy to offer a curative
approach for diabetes is promising, warranting further investigation and
development.
